Modulation of bile secretion by hepatic low-density lipoprotein uptake and by chenodeoxycholic acid and ursodeoxycholic acid treatment in the hamster.
The effects of both apolipoprotein B,E receptor-dependent and receptor-independent uptake of low-density lipoprotein (LDL) in the liver on bile secretion were studied in bile fistula hamsters. Three groups of animals were studied after 4 wk of feeding either a control, chenodeoxycholic acid-, or ursodeoxycholic acid-containing diet. The hepatic receptor-dependent and receptor-independent uptake of LDL was related to both bile flow and biliary lipid secretion. The correlation with bile flow and biliary lipid secretion was positive for the receptor-dependent, but negative for the receptor-independent uptake of LDL. Although the receptor-mediated LDL uptake appeared to exert a strong influence on bile acid-independent bile flow, the receptor-independent uptake showed a significant relation with biliary bile acid excretion. Differences between the two mechanisms of LDL uptake were also evident in the biliary bile acid-cholesterol coupling, which was significantly stronger during receptor-independent than during receptor-dependent uptake of LDL. The effects of LDL uptake on bile secretion were modulated by the experimentally induced changes in both the content and composition of bile acids in the enterohepatic circulation.
Malavolti
M
M
Department of Medicine, George Washington University Medical Center, Washington, D.C. 20037.
Ceryak
S
S
Fromm
H
H
D000818:Animals; D001053:Apolipoproteins / Q000378:metabolism*; D001646:Bile / Q000378:metabolism*; D001658:Biliary Fistula / Q000378:metabolism; D002635:Chenodeoxycholic Acid / Q000494:pharmacology*; D006224:Cricetinae; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D004032:Diet; D004764:Enterohepatic Circulation; D008077:Lipoproteins, LDL / Q000493:pharmacokinetics*; D008099:Liver / Q000378:metabolism*; D008297:Male; D008647:Mesocricetus; D011956:Receptors, Cell Surface / Q000378:metabolism*; D018110:Receptors, Lipoprotein; D014580:Ursodeoxycholic Acid / Q000494:pharmacology*
D001053:Apolipoproteins; D008077:Lipoproteins, LDL; D011956:Receptors, Cell Surface; D018110:Receptors, Lipoprotein; C032531:apolipoprotein B,E receptor; D003840:Deoxycholic Acid; D002635:Chenodeoxycholic Acid; D014580:Ursodeoxycholic Acid